Use your antibodies-online credentials, if available.
No Products on your Comparison List.
Your basket is empty.
Find out more
The C/EBP family of transcription factors regulates viral and cellular CCAAT/enhancer element-mediated transcription. Additionally we are shipping CEBPG Proteins (21) and CEBPG Kits (17) and many more products for this protein.
Showing 10 out of 107 products:
Human Monoclonal CEBPG Primary Antibody for ELISA, WB - ABIN394206
Davila, Froeling, Tan, Bonnard, Boland, Snippe, Hibberd, Seielstad: New genetic associations detected in a host response study to hepatitis B vaccine. in Genes and immunity 2010
Show all 5 references for ABIN394206
Human Polyclonal CEBPG Primary Antibody for WB - ABIN654905
Crawford, Blomquist, Mullins, Yoon, Hernandez, Al-Bagdhadi, Ruiz, Hammersley, Willey: CEBPG regulates ERCC5/XPG expression in human bronchial epithelial cells and this regulation is modified by E2F1/YY1 interactions. in Carcinogenesis 2007
Show all 4 references for ABIN654905
Human Polyclonal CEBPG Primary Antibody for IHC, ELISA - ABIN1533777
Davydov, Bohmann, Krammer, Li-Weber: Cloning of the cDNA encoding human C/EBP gamma, a protein binding to the PRE-I enhancer element of the human interleukin-4 promoter. in Gene 1995
Chicken Polyclonal CEBPG Primary Antibody for WB - ABIN2776382
Mullins, Crawford, Khuder, Hernandez, Yoon, Willey: CEBPG transcription factor correlates with antioxidant and DNA repair genes in normal bronchial epithelial cells but not in individuals with bronchogenic carcinoma. in BMC cancer 2005
The study aimed to identify a small set of genetic signatures that may reliably predict the individuals with a high genetic propensity to heroin addiction. A set of 4 genes (JUN (show JUN Antibodies), CEBPB (show CEBPB Antibodies), PRKCB (show PRKCB Antibodies), ENO2 (show ENO2 Antibodies), or CEBPG) could predict the diagnosis of heroin addiction with the accuracy rate around 85% in our dataset.
These findings suggest that CEBPG may play an oncogenic role in BCP (show OPN1SW Antibodies)-ALL and relies on a mechanism different from CEBPA (show CEBPA Antibodies).
HIV-1 Tat (show TAT Antibodies)-mediated induction of CCL5 (show CCL5 Antibodies) in astrocytes involves NF-kappaB (show NFKB1 Antibodies), AP-1 (show FOSB Antibodies), C/EBPalpha (show CEBPA Antibodies) and C/EBPgamma transcription factors and JAK (show JAK3 Antibodies), PI3K (show PIK3CA Antibodies)/Akt (show AKT1 Antibodies) and p38 MAPK (show MAPK14 Antibodies) signaling pathways
High CEBPG expression correlated with poorer clinical prognoses in several human cancers, and C/EBP gam (show CEBPB Antibodies)ma depletion decreased proliferation and induced senescence in lung tumor cells.
CEBPG mediates the myeloid differentiation arrest induced by CEBPA (show CEBPA Antibodies) deficiency in acute myeloid leukemia (show BCL11A Antibodies).
C/EBPgamma positively regulates wound repair both in vitro and in vivo, at least in part, by affecting EGFR (show EGFR Antibodies) signaling.
Ig/EBP (C/EBPgamma)is constitutively multiubiquitinated & then degraded by the proteasome. Ubiquitination and degradation are suppressed by forming dimers through the leucine zipper domains.
CEBPG is the transcription factor primarily responsible for regulating transcription of key antioxidant and DNA repair genes in non-bronchogenic carcinoma individuals
CEBPG regulates ERCC5 (show ERCC5 Antibodies) expression and this regulation is modified by E2F1 (show E2F1 Antibodies)/YY1 (show YY1 Antibodies) interactions.
Adult Cebpg-/- mice on a mixed strain background show increased early mortality and altered cancer incidence.
HIV-1 Tat (show TAT Antibodies)-mediated induction of CCL5 (show CCL5 Antibodies) in astrocytes involves NF-kappaB (show NFKB1 Antibodies), AP-1 (show JUN Antibodies), C/EBPalpha (show CEBPA Antibodies) and C/EBPgamma transcription factors and JAK (show JAK3 Antibodies), PI3K/Akt (show AKT1 Antibodies) and p38 MAPK (show MAPK14 Antibodies) signaling pathways
The senescence-suppressing activity of C/EBPgamma required its ability to heterodimerize with C/EBPbeta (show CEBPB Antibodies).
CCAAT/enhancer-binding protein gamma is a critical regulator of IL-1beta (show IL1B Antibodies)-induced IL-6 (show IL6 Antibodies) production in alveolar epithelial cells.
The C/EBP family of transcription factors regulates viral and cellular CCAAT/enhancer element-mediated transcription. C/EBP proteins contain the bZIP region, which is characterized by two motifs in the C-terminal half of the protein: a basic region involved in DNA binding and a leucine zipper motif involved in dimerization. The C/EBP family consist of several related proteins, C/EBP alpha, C/EBP beta, C/EBP gamma, and C/EBP delta, that form homodimers and that form heterodimers with each other. CCAAT/enhancer binding protein gamma may cooperate with Fos to bind PRE-I enhancer elements. Two transcript variants encoding the same protein have been found for this gene.
CCAAT/enhancer-binding protein gamma
, CCAAT/enhancer binding protein (C/EBP), gamma
, leucine zipper transcription factor
, c/EBP gamma
, CCAAT/enhancer binding protein gamma
, G-CSF promoter element 1 binding protein
, GPE1-BP (C/EBP gamma)
, GPE1-binding protein
, granulocyte colony-stimulating factor promoter element 1-binding protein
, immunoglobulin enhancer-binding protein 1
, CCAAT/enhancer binding protein ,gamma
, homolog to a human CCAAT/enhancer binding protein - gamma